Macular structure and function and the development of retinopathy in diabetes

REFERENCES

• Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd et al. Retinopathy in diabetes. Diabetes Care 2004; 27 Suppl 1); S84–S87.
   PubMedGoogle Scholar
• Lieth E, Gardner TW, Barber AJ, Antonetti DA, Penn State Retina Research Group. Retinal neurodegeneration: early pathology in diabetes. Clin Exp Optom 2000; 28: 3–8.
   Google Scholar
• Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2001; 27: 283–290.
   Web of Science ®Google Scholar
• Biallosterski C, Van velthoven ME, Michels RP, Schlingemann RO, Devries JH, Verbraak FD. Decreased optical coherence tomography‐measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy. Br J Ophthalmol 2007; 91: 1135–1138.
   PubMed Web of Science ®Google Scholar
• Van dijk HW, Verbraak FD, Stehouwer M, Kok PHN, Garvin MK, Sonka M, Devries JH et al. Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy. Vision Res 2011; 51: 224–228.
   PubMed Web of Science ®Google Scholar
• Nilsson M, Von wendt G, Wanger P, Martin L. Early detection of macular changes in patients with diabetes using Rarebit Fovea Test and optical coherence tomography. Br J Ophthalmol 2007; 91: 1596–1598.
   PubMed Web of Science ®Google Scholar
• Chihara E, Matsuoka T, Ogura Y, Matsumura M. Retinal nerve fibre layer defect as an early manifestation of diabetic retinopathy. Ophthalmology 1993: 100: 1147–1151.
   PubMed Web of Science ®Google Scholar
• Harrison WW, Bearse MA Jr, Ng JS, Jewell NP, Barez S, Burger D, Schneck ME et al. Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci 2011; 52: 772–777.
   Web of Science ®Google Scholar
• Frisén L. New sensitive window on abnormal spatial vision: rarebit probing. Vision Res 2002; 42: 1931–1939.
   Web of Science ®Google Scholar
• Malmer L, Martin L. Microdot test of foveal function: a comparison with visual acuity at high and low contrast. Ophthalmic Physiol Opt 2005; 25: 81–86.
   Web of Science ®Google Scholar
• Nilsson M, Wanger P, Martin L. Perception of very small visual stimuli in the fovea: normative data for the Rarebit Foveal Test. Clin Exp Optom 2006; 89: 81–85.
   Web of Science ®Google Scholar
• Ferris FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94: 91–96.
   PubMed Web of Science ®Google Scholar
• Von wendt, G, Heikkila K. Summanen P. Assessment of diabetic retinopathy using two‐field 60 degrees fundus photography. A comparison between red‐free, black‐and‐white prints and colour transparencies. Acta Ophthalmol Scand 1999; 77: 638–647.
   Google Scholar
• Lai TY, Chan WM, Lai RY, Ngai JW, Li H, Lamm DS. The clinical applications of multifocal electroretinography: a systematic review. Surv Ophthalmol 2007; 52: 61–96.
   PubMed Web of Science ®Google Scholar
• Alvarez Y, Chen K, Reynolds AL, Waghorne N, O'connor JJ, Kennedy BN. Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non‐proliferative diabetic retinopathy. Dis Model Mech 2010; 3: 236–245.
   PubMed Web of Science ®Google Scholar
• Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011; 52: 1156–1163.
   PubMed Web of Science ®Google Scholar
• Sfikakis PP, Grigoropoulos V, Emfietzoglou I, Theodossiadis G, Tentolouris N, Delicha E, Katsiari C et al. Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double‐blind, placebo‐controlled, crossover, 32‐week study. Diabetes Care 2010; 33: 1523–1528.
   PubMed Web of Science ®Google Scholar
• Arnal E, Miranda M, Johnsen‐soriano S, Alvare‐nölting R, Díaz‐llopis M, Araiz J, Cervera E et al. Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Curr Eye Res 2009; 34: 928–938.
   PubMed Web of Science ®Google Scholar
• Fletcher EL, Phipps JA, Ward MM, Vessey KA, Wilkinson‐berka JL. The renin‐angiotensin system in retinal health and disease: its influence on neurons, glia and the vasculature. Prog Retin Eye Res 2010; 29: 284–311.
   PubMed Web of Science ®Google Scholar
• Silva KC, Rosales MA, Biswas SK, Lopes de faria JB, Lopes de faria JM. Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes 2009; 58: 1382–1390.
   PubMed Web of Science ®Google Scholar
• Arnal E, Miranda M, Barcia J, Bosch‐morell F, Romero FJ. Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin‐induced diabetic rat cerebral cortex. Neuroscience 2010; 10: 271–278.
   Google Scholar
• De felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP, Viola KL et al. Protection of synapses against Alzheimer's‐linked toxins: insulin signalling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci USA 2009; 106: 1971–1976.
   PubMed Web of Science ®Google Scholar
• Gandhi GK, Ball KK, Cruz NF, Dienel GA. Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro 2010; 15: 2(2): e00030.
   Web of Science ®Google Scholar
• Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ et al. Impaired insulin and insulin‐like growth factor expression and signaling mechanisms in Alzheimer's disease—is this type 3 diabetes? J Alzheimers Dis 2005; 7: 63–80.
   PubMed Web of Science ®Google Scholar
• De la monte SM, Tong M, Lester‐coll N, Plater M Jr, Wands JR. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimer's Dis 2006; 10: 189–109.
   Web of Science ®Google Scholar
• Kroner Z. The relationship between Alzheimer's disease and diabetes: type 3 diabetes? Altern Med Rev 2009: 14: 373–379.
   PubMedGoogle Scholar
• Johnson EJ. Age‐related macular degeneration and antioxidant vitamins: recent findings. Curr Opin Clin Nutr Metab Care 2010; 13: 28–33.
   PubMed Web of Science ®Google Scholar
• Winther C, Frisén L. A compact rarebit test for macular diseases. Br J Ophthalmol 2010; 94: 324–327.
   Web of Science ®Google Scholar